Relay Therapeutics’ Dynamo platform combines machine learning and physics-based simulation to target dynamic protein conformations for oncology and genetic disease therapies. RLY-2608 targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback